Mandate

Vinge advised LKAB in connection with its investment in the sustainable rare earth elements producer REEtec.

November 08, 2022 Banking and Finance

Vinge has advised Luossavaara-Kiirunavaara AB (publ) (“LKAB”) in connection with its investment in, REEtec Holding AS (“REEtec”). LKAB invests in the financing round, that totals NOK 1.2 billion, to become the largest shareholder of REEtec.

REEtec has developed an innovative and sustainable technology for the separation of rare earth elements and the new financing will be used to finance the construction of its first separation plant which will be located in Herøya, Norway. The REEtec process combines high efficiency with up to 90 per cent. lower carbon emissions.

The demand for rare earth elements, which is driven by e.g. production of electric cars and wind turbines, is expected to increase fivefold by 2030. As Europe is dependent on imports of these critical minerals, LKAB’s investment in REEtec is underpinning the European Union’s strategy to increase Europe’s self-sufficiency. The new separation plant in Herøya will have a production of 720 tonnes of the earth elements Neodymium and Praseodymium, equivalent to five per cent. of Europe's needs and the majority of the production will be sold to the car industry. A second plant is planned to be built in Herøya in 2026, which will also process material from LKAB’s extraction of rare earth elements from mine tailings, processed in the industrial park in Luleå that is planned for production from 2027.

Wiersholm acted as legal counsel to LKAB as to Norwegian law and PwC acted as financial advisor to LKAB.

Vinge’s team consisted of Olof Jisland, Albert Wållgren and Arvid Weimers.

Related

Vinge has advised Course Corrected VC on the establishment of Course Corrected VC Fund II

Vinge has advised Course Corrected VC on the establishment and structuring of their second fund, Course Corrected VC Fund II (the “Fund”).
November 12, 2026

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026